Huixun Jia

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Clostridium Difficile

Squamous Cell Carcinoma

Top Venues

Nature communications

Nature medicine

Journal of gynecologic oncology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rong Jiang, Yanling Feng, Yulian Chen, Xi Cheng, Ting Yan Shi, Wen Gao, Huixun Jia, Shiyang Jiang, Yi Guo, Xiao Huang, Dongsheng Tu, Yuqin Zhang, Huijuan Yang, Ping Zhang, Jihong Liu, Jianqing Zhu, Rong Yu Zang, null null
Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial. Nature medicine 30 (8) (2024)
Rong Jiang, Yanling Feng, Yulian Chen, Xi Cheng, Ting Yan Shi, Wen Gao, Huixun Jia, Shiyang Jiang, Yi Guo, Xiao Huang, Dongsheng Tu, Yuqin Zhang, Huijuan Yang, Ping Zhang, Jihong Liu, Jianqing Zhu, Rong Yu Zang, null null
Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial. Nature medicine (2024)
Rong Jiang, Yanling Feng, Yulian Chen, Xi Cheng, Ting Yan Shi, Wen Gao, Huixun Jia, Shiyang Jiang, Yi Guo, Xiao Huang, Dongsheng Tu, Yuqin Zhang, Huijuan Yang, Ping Zhang, Jihong Liu, Jianqing Zhu, Rong Yu Zang, null null
Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial. Nature medicine 30 (8) (2024)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Publisher Correction: Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 14 (1) (2023)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Publisher Correction: Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 14 (1) (2023)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Ting Yan Shi, Libing Xiang, Jian Qing Zhu, Ji-Hong Liu, Ping Zhang, Hua Ying Wang, Yanling Feng, Tao Zhu, Yingli Zhang, Aijun Yu, Wei Jiang, Xipeng Wang, Yaping Zhu, Sufang Wu, Yincheng Teng, Jiejie Zhang, Rong Jiang, Wei Zhang, Huixun Jia, Rong Yu Zang
Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study. Journal of gynecologic oncology 33 (4) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Shiqi Yang, Tong Li, Huixun Jia, Min Gao, Yiming Li, Xiaoling Wan, Zhen Huang, Min Li, Yuanqi Zhai, Xiaomeng Li, Xiaotong Yang, Tao Wang, Jian Liang, Qing Gu, Xueting Luo, Lei Qian, Shujie Lu, Junjian Liu, Yanping Song, Fenghua Wang, Xiaodong Sun, Dechao Yu
Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy. Science translational medicine 14 (647) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Ting Yan Shi, Sheng Yin, Jian Qing Zhu, Ping Zhang, Ji-Hong Liu, Yaping Zhu, Sufang Wu, Xiao-Jun Chen, Xipeng Wang, Yincheng Teng, Tao Zhu, Aijun Yu, Yingli Zhang, Yanling Feng, He Huang, Xiujuan Zhao, Yanli Li, Wei Jiang, Ping Zhang, Jiarui Li, Zhihong Ai, Wei Zhang, Huixun Jia, Yuqin Zhang, Rong Jiang, Jiejie Zhang, Wen Gao, Yuting Luan, Rong Yu Zang
A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study. Journal of gynecologic oncology 31 (3) (2021)
Rong Jiang, Jian Qing Zhu, Jae-Weon Kim, Ji Hong Liu, Kazuyoshi Kato, Hee Seung Kim, Yuqin Zhang, Ping Zhang, Tao Zhu, Daisuke Aoki, Aijun Yu, Xiao-Jun Chen, Xipeng Wang, Ding Zhu, Wei Zhang, Huixun Jia, Ting Yan Shi, Wen Gao, Sheng Yin, Yanling Feng, Libing Xiang, Aikou Okamoto, Rong Yu Zang
Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept. Journal of gynecologic oncology 31 (5) (2021)